Citations

Showing 10 of 108083 citations.

Validation of stricture length, duration and obstructive symptoms as predictors for intervention in ileal stricturing Crohn's disease
Ouali, Sara El , Baker, Mark E. , Lyu, Ruishen, Bruining, David H. , Click, Benjamin , Qazi, Taha , Cohen, Benjamin L., Rieder, Florian , El Ouali, Sara , Fletcher, Joel G. , Holubar, Stefan D.

Mayo Clinic

United European Gastroenterology Journal | December 7, 2022 | Volume: 10 | Issue: 9 | Pages: 958-972

10.1002/ueg2.12314 | PMID 36479841 Get It

AbstractBackgroundRisk factors for intervention in terminal ileal (TI) stricturing Crohn's disease (CD) are poorly defined. Novel and rigorous definitions for TI strictures recently became available.ObjectiveWe aimed to describe the rates of symptoms or need for endoscopic balloon dilation (EBD) or surgery as well as risk factors of progression in a well‐defined stricturing CD cohort.MethodsConsecutive adult patients with non‐penetrating stricturing TI CD, as defined by centrally‐read magnetic resonance enterography CONSTRICT criteria, were separated into a derivation and validation cohort. Clinical and imaging characteristics were collected following prespecified scoring conventions. Primary outcome was a composite endpoint of EBD or surgery (“intervention”). Multivariable analysis was performed.ResultsEighty‐six patients (48.8% female, median age 36 years) met selection criteria, 17.4% had prior EBD, 59.3% previously received biologics and 58.1% of strictures were anastomotic. Median follow‐up was 63.4 [95% CI: 57, 68.9] months. In the derivation cohort, at 12 and 48 months, 26% and 45% of patients had intervention, respectively. Multivariable analysis showed obstructive symptoms (Hazard ratio [HR] 1.444; 95% CI 1.126–1.852), stricture duration (HR 0.974; 95% CI, 0.954–0.995) and length (HR 1.039; 95% CI, 1.011–1.069) predicted intervention. The concordance index for split‐sample validation was 0.74 and 0.67, respectively. Biologics were not associated with intervention. An online risk calculator was constructed.ConclusionIn patients with TI stricturing CD, 26% and 45% required intervention at 1 and 4 years. Obstructive symptoms, stricture duration and length were independent and validated predictors of the need for intervention. These findings are important for clinical practice and aid in the design of future trials for CD strictures.
Evaluating the Impact of Breast and Nipple Sensation on Quality-of-Life after Nipple-sparing Mastectomy with Implant Reconstruction: Long-term Outcomes Utilizing Breast-Q
Spronsen, Nicole R Van, Armstrong, Valerie, Rebecca, Alanna M. , Casey, William J., Kruger, Erwin A., Pockaj, Barbara A. , Teven, Chad M. , Spronsen, Nicole Van , Hammond, Jacob B. , Kandi, Lyndsay A. , Kosiorek, Heidi , Cronin, Patricia A

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | December 7, 2022 | Volume: 10 | Issue: 11S | Pages: 1-2

10.1097/01.gox.0000905076.77838.ec Get It

Catheter design primer for neurointerventionalists
Bilgin, Cem , Hutar, Jared, Li, Jiahui , Ribó, Marc , Kallmes, David F. , Ribo, Marc , Li, Jiahui , Castaño, Óscar

Mayo Clinic

Journal of NeuroInterventional Surgery | December 7, 2022 | Volume: 15 | Issue: 11 | Pages: 1117-1121

10.1136/jnis-2022-019567 | PMID 36597952 Get It

Neurovascular catheter technology has rapidly evolved over the past decade. While performance characteristics are well known to the practitioner, the design features of these new-generation catheters and their implications on performance metrics remain a mystery to most clinicians due to the limited number of available resources. This knowledge gap hampers informed device choices and also limits collaboration between clinicians and engineers. To aid fellow neurointerventionalists, in this primer we have summarized the basic concepts of catheter design and construction.
Faculty Opinions recommendation of Effectiveness of Intrarectal Povidone-iodine Cleansing Plus Formalin Disinfection of the Needle Tip in Decreasing Infectious Complications After Transrectal Prostate Biopsy: A Randomized Controlled Trial.
Humphreys, Mitchell R. , Heidenberg, Daniel

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | December 7, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.742292886.793596848 Get It

A Systematic Review Supporting the Endocrine Society Guidelines: Management of Diabetes and High Risk of Hypoglycemia
Roldan, Victor D. Torres , Urtecho, Meritxell , Nayfeh, Tarek , Firwana, Mohammed , Muthusamy, Kalpana , Abd‐Rabu, Rami , Maraboto, Andrea , Qoubaitary, Amjad, Lieb, David C. , McCall, Anthony L. , Torres Roldan, Victor D , Hasan, Bashar , Abd-Rabu, Rami, Murad, Mohammad Hassan, Nayfeh, Tarek , Firwana, Mohammed M , Hasan, Bashar , Prokop, Larry J. , Wang, Zhen , Murad, M. Hassan

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | December 7, 2022 | Volume: 108 | Issue: 3 | Pages: 592-603

10.1210/clinem/dgac601 | PMID 36477885 Get It

Abstract Context Interventions targeting hypoglycemia in people with diabetes are important for improving quality of life and reducing morbidity and mortality. Objective To support development of the Endocrine Society Clinical Practice Guideline for management of individuals with diabetes at high risk for hypoglycemia. Methods We searched several databases for studies addressing 10 questions provided by a guideline panel from the Endocrine Society. Meta-analysis was conducted when feasible. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess certainty of evidence. Results We included 149 studies reporting on 43 344 patients. Continuous glucose monitoring (CGM) reduced episodes of severe hypoglycemia in patients with type 1 diabetes (T1D) and reduced the proportion of patients with hypoglycemia (blood glucose [BG] levels <54 mg/dL). There were no data on use of real-time CGM with algorithm-driven insulin pumps vs multiple daily injections with BG testing in people with T1D. CGM in outpatients with type 2 diabetes taking insulin and/or sulfonylureas reduced time spent with BG levels under 70 mg/dL. Initiation of CGM in hospitalized patients at high risk for hypoglycemia reduced episodes of hypoglycemia with BG levels lower than 54 mg/dL and time spent under 54 mg/dL. The proportion of patients with hypoglycemia with BG levels lower than 70 mg/dL and lower than 54 mg/dL detected by CGM was significantly higher than point-of-care BG testing. We found no data evaluating continuation of personal CGM in the hospital. Use of an inpatient computerized glycemic management program utilizing electronic health record data was associated with fewer patients with and episodes of hypoglycemia with BG levels lower than 70 mg/dL and fewer patients with severe hypoglycemia compared with standard care. Long-acting basal insulin analogs were associated with less hypoglycemia. Rapid-acting insulin analogs were associated with reduced severe hypoglycemia, though there were more patients with mild to moderate hypoglycemia. Structured diabetes education programs reduced episodes of severe hypoglycemia and time below 54 mg/dL in outpatients taking insulin. Glucagon formulations not requiring reconstitution were associated with longer times to recovery from hypoglycemia, although the proportion of patients who recovered completely from hypoglycemia was not different between the 2 groups. Conclusion This systematic review summarized the best available evidence about several interventions addressing hypoglycemia in people with diabetes. This evidence base will facilitate development of clinical practice guidelines by the Endocrine Society.
Transforming Atrial Fibrillation Research to Integrate Social Determinants of Health
Benjamin, Emelia J. , Thomas, Kevin L. , Go, Alan S. , Desvigne‐Nickens, Patrice , Alonso, Álvaro , Essien, Utibe R. , Hernandez, Inmaculada , Hills, Mellanie True , Matlock, Daniel D. , O’Brien, Emily C. , Russo, Andrea M. , Soliman, Elsayed Z. , Cooper, Lawton S. , Alonso, Alvaro , Matlock, Daniel D , Benjamin, Emelia J , Essien, Utibe R , Albert, Christine M. , Chamberlain, Alanna M. , Kershaw, Kiarri N. , Levy, Phillip David , Magnani, Jared W. , Rodríguez, Carlos J. , Al‐Khatib, Sana M.

Mayo Clinic

JAMA Cardiology | December 7, 2022 | Volume: 8 | Issue: 2 | Pages: 182

10.1001/jamacardio.2022.4091 | PMID 36478155 Get It

Importance Only modest attention has been paid to the contributions of social determinants of health to atrial fibrillation (AF) risk factors, diagnosis, symptoms, management, and outcomes. The diagnosis of AF provides unique challenges exacerbated by the arrhythmia’s often paroxysmal nature and individuals’ disparate access to health care and technologies that facilitate detection. Social determinants of health affect access to care and management decisions for AF, increasing the likelihood of adverse outcomes among individuals who experience systemic disadvantages. Developing effective approaches to address modifiable social determinants of health requires research to eliminate the substantive inequities in health care delivery and outcomes in AF. Observations The National Heart, Lung, and Blood Institute convened an expert panel to identify major knowledge gaps and research opportunities in the field of social determinants of AF. The workshop addressed the following social determinants: (1) socioeconomic status and access to care; (2) health literacy; (3) race, ethnicity, and racism; (4) sex and gender; (5) shared decision-making in systemically disadvantaged populations; and (6) place, including rurality, neighborhood, and community. Many individuals with AF have multiple adverse social determinants, which may cluster in the individual and in systemically disadvantaged places (eg, rural locations, urban neighborhoods). Cumulative disadvantages may accumulate over the life course and contribute to inequities in the diagnosis, management, and outcomes in AF. Conclusions and Relevance Workshop participants identified multiple critical research questions and approaches to catalyze social determinants of health research that address the distinctive aspects of AF. The long-term aspiration of this work is to eradicate the substantive inequities in AF diagnosis, management, and outcomes across populations.
MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology
Dutta, Ankit K. , Alberge, Jean-Baptiste , Lightbody, Elizabeth D. , Boehner, Cody J. , Dunford, Andrew , Sklavenitis‐Pistofidis, Romanos , Mouhieddine, Tarek H. , Cowan, Annie , Su, Nang Kham , Horowitz, Erica , Barr, Hadley , Hevenor, Laura , Perry, Jacqueline , Cao, Amanda , Lin, Ziao , Kuhr, Frank K. , Mastro, Richard G. Del , Greipp, Patricia T. , Auclair, Daniel , Ghobrial, Irene M. , Cowan, Annie N , Horowitz, Erica M , Beckwith, Jenna B , Perry, Jacqueline , Cao, Amanda , Lin, Ziao , Kuhr, Frank K , Mastro, Richard G Del , Nadeem, Omar , Greipp, Patricia T , Stewart, Chip , Auclair, Daniel , Getz, Gad , Ghobrial, Irene M , Sklavenitis-Pistofidis, Romanos , Su, Nang K , Alberge, Jean-Baptiste , Nadeem, Omar , Getz, Gad

Mayo Clinic

Cancer Discovery | December 7, 2022 | Volume: 13 | Issue: 2 | Pages: 348-363

10.1158/2159-8290.cd-22-0482 | PMID 36477267 Get It

Abstract Multiple myeloma (MM) develops from well-defined precursor stages; however, invasive bone marrow (BM) biopsy limits screening and monitoring strategies for patients. We enumerated circulating tumor cells (CTC) from 261 patients (84 monoclonal gammopathy of undetermined significance, 155 smoldering multiple myeloma, and 22 MM), with neoplastic cells detected in 84%. We developed a novel approach, MinimuMM-seq, which enables the detection of translocations and copy-number abnormalities through whole-genome sequencing of highly pure CTCs. Application to CTCs in a cohort of 51 patients, 24 with paired BM, was able to detect 100% of clinically reported BM biopsy events and could replace molecular cytogenetics for diagnostic yield and risk classification. Longitudinal sampling of CTCs in 8 patients revealed major clones could be tracked in the blood, with clonal evolution and shifting dynamics of subclones over time. Our findings provide proof of concept that CTC detection and genomic profiling could be used clinically for monitoring and managing disease in MM. Significance: In this study, we established an approach enabling the enumeration and sequencing of CTCs to replace standard molecular cytogenetics. CTCs harbored the same pathognomonic MM abnormalities as BM plasma cells. Longitudinal sampling of serial CTCs was able to track clonal dynamics over time and detect the emergence of high-risk genetic subclones. This article is highlighted in the In This Issue feature, p. 247
Prognostic Value of Left Ventricular Global Longitudinal Strain in Patients With Congenital Heart Disease
Egbe, Alexander C. , Miranda, William R. , Anderson, Jason H. , Pellikka, Patricia A. , Connolly, Heidi M. , Pellikka, Patricia A , Anderson, Jason

Mayo Clinic

Circulation: Cardiovascular Imaging | December 7, 2022 | Volume: 15 | Issue: 12 | Pages: No page available

10.1161/circimaging.122.014865 | PMID 36475454 Get It

Background: Left ventricular global longitudinal strain (LVGLS) has been shown to improve risk stratification in patients with LV systolic dysfunction and subsequent recovery of LV ejection fraction (LVEF) in the acquired heart disease population. The purpose of this study was to assess the relationship between LVGLS and cardiovascular events (heart failure hospitalization, sustained ventricular tachycardia/appropriate shock, heart transplant, or cardiovascular death) and deterioration in LVEF (absolute decrease in LVEF ≥10% to LVEF <50%) in adults with congenital heart disease. Methods: Retrospective cohort study of congenital heart disease patients with previous diagnosis of LV systolic dysfunction (LVEF <50%) and subsequent recovery of LVEF (absolute increase in LVEF of ≥10% to LVEF ≥50%) on subsequent echocardiogram (index echocardiogram). Based on the index echocardiogram, patients were divided into normal LVGLS (absolute LVGLS >18%) versus abnormal LVGLS (absolute LVGLS ≤18%) groups. Results: Of 193 patients with recovered LVEF, 86 (45%) had normalization of LVGLS at index echocardiogram. A higher absolute LVGLS and use of renin angiotensin aldosterone system antagonist was associated with a lower risk of cardiovascular events and subsequent deterioration in LVEF, while hypertension was associated with higher risk of cardiovascular events and deterioration in LVEF. Conclusions: These results suggest that patients with congenital heart disease with recovered LVEF remained at risk for adverse outcomes, and LVGLS can be used to identify patients at risk for adverse outcomes. Medical therapy for heart failure and treatment of hypertension may reduce the risk of adverse outcome, but these findings require empirical validation, hence the need for a clinical trial.
Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline
McCall, Anthony L. , Lieb, David C. , Gianchandani, Roma , MacMaster, Heidemarie Windham, Maynard, Gregory A. , Murad, M. Hassan , Wolfsdorf, Joseph I. , Wright, Robin, Wiercioch, Wojtek , Wiercioch, Wojtek , Murad, M Hassan , Seaquist, Elizabeth R.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | December 7, 2022 | Volume: 108 | Issue: 3 | Pages: 529-562

10.1210/clinem/dgac596 | PMID 36477488 Get It

Abstract Context Hypoglycemia in people with diabetes is common, especially in those taking medications such as insulin and sulfonylureas (SU) that place them at higher risk. Hypoglycemia is associated with distress in those with diabetes and their families, medication nonadherence, and disruption of life and work, and it leads to costly emergency department visits and hospitalizations, morbidity, and mortality. Objective To review and update the diabetes-specific parts of the 2009 Evaluation and Management of Adult Hypoglycemic Disorders: Endocrine Society Clinical Practice Guideline and to address developing issues surrounding hypoglycemia in both adults and children living with diabetes. The overriding objectives are to reduce and prevent hypoglycemia. Methods A multidisciplinary panel of clinician experts, together with a patient representative, and methodologists with expertise in evidence synthesis and guideline development, identified and prioritized 10 clinical questions related to hypoglycemia in people living with diabetes. Systematic reviews were conducted to address all the questions. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess the certainty of evidence and make recommendations. Results The panel agreed on 10 questions specific to hypoglycemia risk and prevention in people with diabetes for which 10 recommendations were made. The guideline includes conditional recommendations for use of real-time continuous glucose monitoring (CGM) and algorithm-driven insulin pumps in people with type 1 diabetes (T1D), use of CGM for outpatients with type 2 diabetes at high risk for hypoglycemia, use of long-acting and rapid-acting insulin analogs, and initiation of and continuation of CGM for select inpatient populations at high risk for hypoglycemia. Strong recommendations were made for structured diabetes education programs for those at high risk for hypoglycemia, use of glucagon preparations that do not require reconstitution vs those that do for managing severe outpatient hypoglycemia for adults and children, use of real-time CGM for individuals with T1D receiving multiple daily injections, and the use of inpatient glycemic management programs leveraging electronic health record data to reduce the risk of hypoglycemia. Conclusion The recommendations are based on the consideration of critical outcomes as well as implementation factors such as feasibility and values and preferences of people with diabetes. These recommendations can be used to inform clinical practice and health care system improvement for this important complication for people living with diabetes.
Characterizing variability of electronic health record-driven phenotype definitions
Brandt, Pascal , Luo, Yuan , Pacheco, Jennifer A. , Walunas, Theresa L. , Håkonarson, Håkon , Liu, Cong , Walton, Nephi , Carrell, David , Crane, Paul K. , Chute, Christopher G. , Carroll, Robert J. , Denny, Joshua C. , Ramirez, Andrea H. , Wei, Wei‐Qi, Pathak, Jyoti , Wiley, Laura K. , Richesson, Rachel , Starren, Justin , Rasmussen, Luke V. , Brandt, Pascal S , Luo, Yuan , Pacheco, Jennifer A , Hakonarson, Hakon , Liu, Cong , Carrell, David S , Chute, Christopher G , Wiley, Laura K , Starren, Justin B , Rasmussen, Luke V , Denny, Joshua C , Richesson, Rachel L , Wei, Wei-Qi , Walunas, Theresa L , Kho, Abel , Hripcsak, George , Shang, Ning , Weng, Chunhua , Larson, Eric B. , Kullo, Iftikhar J. , Pathak, Jyoti

Mayo Clinic

Journal of the American Medical Informatics Association | December 7, 2022 | Volume: 30 | Issue: 3 | Pages: 427-437

10.1093/jamia/ocac235 | PMID 36474423 Get It

AbstractObjectiveThe aim of this study was to analyze a publicly available sample of rule-based phenotype definitions to characterize and evaluate the variability of logical constructs used.Materials and MethodsA sample of 33 preexisting phenotype definitions used in research that are represented using Fast Healthcare Interoperability Resources and Clinical Quality Language (CQL) was analyzed using automated analysis of the computable representation of the CQL libraries.ResultsMost of the phenotype definitions include narrative descriptions and flowcharts, while few provide pseudocode or executable artifacts. Most use 4 or fewer medical terminologies. The number of codes used ranges from 5 to 6865, and value sets from 1 to 19. We found that the most common expressions used were literal, data, and logical expressions. Aggregate and arithmetic expressions are the least common. Expression depth ranges from 4 to 27.DiscussionDespite the range of conditions, we found that all of the phenotype definitions consisted of logical criteria, representing both clinical and operational logic, and tabular data, consisting of codes from standard terminologies and keywords for natural language processing. The total number and variety of expressions are low, which may be to simplify implementation, or authors may limit complexity due to data availability constraints.ConclusionsThe phenotype definitions analyzed show significant variation in specific logical, arithmetic, and other operators but are all composed of the same high-level components, namely tabular data and logical expressions. A standard representation for phenotype definitions should support these formats and be modular to support localization and shared logic.